click below
click below
Normal Size Small Size show me how
Analgesics 411
Pain
Question | Answer |
---|---|
Disturbance of function or pathological change in a nerve | Neuropathy |
Least stimulus intensity at which a subject perceives pain | Pain Threshold |
Requiring more analgesia for the same level of pain | Pain tolerance |
Tissue damaging stimulus | Noxious stimulus |
Transient (< 3 months) | Acute Pain |
An event that has a beginning and an end | Acute Pain |
Well-defined | Acute Pain |
Temporal onset | Acute Pain |
Serves biological function | Acute pain |
Usually supportive physical findings | Acute pain |
Persistent (> 3 months) | Chronic Pain |
Impossible to predict end | Chronic Pain |
Lacks meaning | Chronic Pain |
No biological function | Chronic Pain |
Physical findings inconclusive | Chronic Pain |
Peripheral neuropathy-long term nerve damage | Chronic Pain |
Usually acute, response to analgesics usually good | Nociceptive Pain |
Direct stimulation of pain fibers | Somatic Pain |
Dull, aching, throbbing pain | Somatic Pain |
Direct stimulation of pain fibers in internal organs, often poorly localized | Visceral Pain |
Deep, aching, squeezing pain | Visceral Pain |
Chronic, response to analgesics usually poor, may respond to aduvants | Neuropathic pain |
Burning, shooting, tingling pain | Neuropathic pain |
Aim-Pain relief | Acute Pain |
Sedation often desirable | Acute Pain |
Duration 2-4 hrs | Acute Pain |
Regular and PRN Interval | Acute Pain |
Standardized dose | Acute Pain |
Parenteral Route | Acute pain |
Use of adjuvants uncommon | Acute pain |
Aim-pain prevention | Chronic Pain |
Sedation usually undesirable | Chronic Pain |
Duration-as long as possible | Chronic Pain |
Regular (anticipatory) interval | Chronic Pain |
Individualized dose | Chronic Pain |
Oral Route | Chronic Pain |
Use of adjuvants common | Chronic Pain |
Drugs w/ ceiling effect | NSAIDs, ASA, APAP |
Analgesic and antipyretic activity | APAP |
Analgesic, antipyretic, anti-inflammatory activity | NSAIDs |
Analgesic, antipyretic, anti-inflammatory, and antiplatelet activity | ASA |
Avoid aspirin in: | Childres w/ viral syndromes, may precipitate Reye's syndrome |
NSAIDs also available parenteral | Ketorolac, Indomethocin |
Decreased ulcer incidence in high-risk pts | COX-2 Inhibitors |
Opioids most dangerous/common ADRs | Respiratory depression, Constipation |
Morphine and its cogeners | Codeine, hydrocodone, hydromorphone, levorphanol, oxycodone |
Meperidine and its cogener | Fentanyl |
Other opiate | Methadone |
Active metabolite can accumulate and cause agitation and seizures | Meperidine |
More potent, shorter acting, large rapid injection, can cause rigid chest syndrome | Fentanyl |
Narcotic maintenance programs, chronic pain, not for acute pain, delayed onset and long duration | Methadone |
MOA same as opiates, lower abuse potential | Partial agonists |
Ceiling effect on analgesia and respiratory depression, may precipitate w/drawal in dependent pts, increase myocardial workload | Partial agonists |
Binds but doesn't stimulate opiate receptors. Competes with opiates. Short acting, parenteral only | Naloxone (Narcan) |
Long term use in formerly dependent pts, oral only | Naltrexone |
Both reversal and long term use, parenteral only (2 strengths) | Nalmefene |
Tinnitus, GI upset, hypersensitivity | ASA ADRs |
GI distress, renal insufficiency | NSAIDs ADRs |
Increased risk of serious CV thrombotic effects | COX-2 Inhibitors |